INS - insulin Gene
Species: Felis catus
Gene Type: protein coding
Gene ID: 493804
INS Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001009272.1 | NP_001009272.1 | insulin precursor |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
insulin |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-101056 | Brensocatib | Inhibitor | 99.88% | Yes |
| HY-B0606 | Diquafosol tetrasodium | Agonist | 99.0% | Unkown |
| HY-112870 | Firmonertinib | Inhibitor | 99.89% | Unkown |
| HY-135815 | Mobocertinib | Inhibitor | 99.60% | Yes |
| HY-112870A | Firmonertinib mesylate | Inhibitor | 99.97% | Unkown |
| HY-135815A | Mobocertinib succinate | Inhibitor | 99.83% | Yes |
| HY-135815B | Mobocertinib mesylate | Inhibitor | / | Unkown |
| HY-B0606A | Diquafosol | / | Unkown |
Clinical Phase
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-109163 | Treprostinil palmitil | Agonist | 99.62% | Phase 3 |
| HY-160623 | Rentosertib | 99.96% | Phase 2 | |
| HY-13529 | Globalagliatin | Activator | 99.45% | Phase 2 |
| HY-155537 | Pruvonertinib | Inhibitor | 99.50% | Phase 2 |
| HY-123490 | Regrelor disodium | Antagonist | 99.89% | Phase 2 |
Inhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-P991888 | INCA033989 | Inhibitor | 98.12% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(48)
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service